skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 243,121  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Breast Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Article
Add to My Research

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08766-9 ;PMID: 34556087

Full text available

2
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Material Type:
Article
Add to My Research

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Cancer science, 2020-08, Vol.111 (8), p.2708-2717 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;ISSN: 1349-7006 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14537 ;PMID: 32573845

Full text available

3
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants
Material Type:
Article
Add to My Research

Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants

PLoS medicine, 2020-07, Vol.17 (7), p.e1003178 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Larsson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Larsson et al 2020 Larsson et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003178 ;PMID: 32701947

Full text available

4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Material Type:
Article
Add to My Research

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Molecular cancer, 2023-08, Vol.22 (1), p.1-138, Article 138 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01827-6 ;PMID: 37596643

Full text available

5
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Material Type:
Article
Add to My Research

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1259-z ;PMID: 31196207

Full text available

6
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Material Type:
Article
Add to My Research

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature

PloS one, 2012-12, Vol.7 (12), p.e50946-e50946 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Zhang et al 2012 Zhang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0050946 ;PMID: 23284651

Full text available

7
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Material Type:
Article
Add to My Research

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

PloS one, 2013-08, Vol.8 (8), p.e71583 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Franciosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Franciosi et al 2013 Franciosi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0071583 ;PMID: 23936520

Full text available

8
Cancer statistics, 2022
Material Type:
Article
Add to My Research

Cancer statistics, 2022

CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21708 ;PMID: 35020204

Full text available

9
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Material Type:
Article
Add to My Research

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

Cell proliferation, 2021-10, Vol.54 (10), p.e13115-n/a [Peer Reviewed Journal]

2021 The Authors. Published by John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0960-7722 ;EISSN: 1365-2184 ;DOI: 10.1111/cpr.13115 ;PMID: 34464477

Full text available

10
Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
Material Type:
Article
Add to My Research

Hormone Replacement Therapy in Cancer Survivors – Review of the Literature

Pathology oncology research, 2020-01, Vol.26 (1), p.63-78 [Peer Reviewed Journal]

The Author(s) 2019 ;ISSN: 1219-4956 ;EISSN: 1532-2807 ;DOI: 10.1007/s12253-018-00569-x

Digital Resources/Online E-Resources

11
Long non‑coding RNA GAS5 in human cancer (Review)
Material Type:
Article
Add to My Research

Long non‑coding RNA GAS5 in human cancer (Review)

Oncology letters, 2020-09, Vol.20 (3), p.2587-2594

COPYRIGHT 2020 Spandidos Publications ;COPYRIGHT 2020 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2020 ;Copyright: © Yang et al. 2020 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2020.11809 ;PMID: 32782576

Full text available

12
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Material Type:
Article
Add to My Research

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667

Full text available

13
Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study
Material Type:
Article
Add to My Research

Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study

eLife, 2023-11, Vol.12 [Peer Reviewed Journal]

2023, Ruan, Huang et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023, Ruan, Huang et al 2023 Ruan, Huang et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/eLife.86379 ;PMID: 37917154

Full text available

14
Trends in the incidence and mortality of cancer in Saudi Arabia
Material Type:
Article
Add to My Research

Trends in the incidence and mortality of cancer in Saudi Arabia

Saudi medical journal, 2018-12, Vol.39 (12), p.1259-1262 [Peer Reviewed Journal]

COPYRIGHT 2018 Saudi Medical Journal ;Saudi Medical Journal 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial – Share Alike License http://creativecommons.org/licenses/by-nc-sa/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © Saudi Medical Journal 2018 ;ISSN: 0379-5284 ;EISSN: 1658-3175 ;DOI: 10.15537/smj.2018.12.23348 ;PMID: 30520511

Full text available

15
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer
Material Type:
Article
Add to My Research

Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer

BMC endocrine disorders, 2024-01, Vol.24 (1), p.9-5, Article 9 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1472-6823 ;EISSN: 1472-6823 ;DOI: 10.1186/s12902-024-01539-y ;PMID: 38212751

Full text available

16
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Material Type:
Article
Add to My Research

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258

Full text available

17
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
Material Type:
Article
Add to My Research

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0972-8 ;PMID: 30927911

Full text available

18
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
Material Type:
Article
Add to My Research

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

Molecular cancer, 2019-02, Vol.18 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-018-0935-5 ;PMID: 30717751

Full text available

19
Effect of CCR2-V64I on the Susceptibility of Patients to Cancer
Material Type:
Article
Add to My Research

Effect of CCR2-V64I on the Susceptibility of Patients to Cancer

European journal of cancer care, 2023-06, Vol.2023, p.1-10 [Peer Reviewed Journal]

Copyright © 2023 Xue-Jiao Lu et al. ;COPYRIGHT 2023 Hindawi Limited ;Copyright © 2023 Xue-Jiao Lu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;ISSN: 1365-2354 ;ISSN: 0961-5423 ;EISSN: 1365-2354 ;DOI: 10.1155/2023/7630422

Full text available

20
Exosome-based immunotherapy: a promising approach for cancer treatment
Material Type:
Article
Add to My Research

Exosome-based immunotherapy: a promising approach for cancer treatment

Molecular cancer, 2020-11, Vol.19 (1), p.1-160, Article 160 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01278-3 ;PMID: 33183286

Full text available

Results 1 - 20 of 243,121  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (190,490)

Refine My Results

Creation Date 

From To
  1. Before 1961  (246)
  2. 1961 To 1976  (313)
  3. 1977 To 1992  (3,316)
  4. 1993 To 2009  (57,179)
  5. After 2009  (181,886)
  6. More options open sub menu

Subject 

  1. Science & Technology  (161,365)
  2. Life Sciences & Biomedicine  (142,387)
  3. Humans  (106,940)
  4. Female  (87,185)
  5. Oncology  (80,347)
  6. Tumors  (56,509)
  7. Cancer  (51,848)
  8. Cancer Therapies  (40,646)
  9. Middle Aged  (39,249)
  10. Metastasis  (38,188)
  11. Chemotherapy  (32,898)
  12. Breast Neoplasms - Pathology  (32,593)
  13. Adult  (31,425)
  14. Patients  (29,378)
  15. Proteins  (28,676)
  16. Aged  (28,544)
  17. Gene Expression  (26,275)
  18. Health Aspects  (25,708)
  19. Medicine  (24,306)
  20. More options open sub menu

Language 

  1. English  (239,337)
  2. Japanese  (20,762)
  3. Portuguese  (962)
  4. Spanish  (930)
  5. French  (883)
  6. German  (870)
  7. Chinese  (773)
  8. Persian  (453)
  9. Russian  (313)
  10. Turkish  (269)
  11. Norwegian  (177)
  12. Korean  (174)
  13. Polish  (165)
  14. Czech  (67)
  15. Catalan  (57)
  16. Croatian  (48)
  17. Swedish  (47)
  18. Indonesian  (36)
  19. Ukrainian  (24)
  20. Italian  (23)
  21. More options open sub menu

Searching Remote Databases, Please Wait